Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118516426A reveals enzymatic route for chiral intermediates. High purity, mild conditions, cost-effective for pharma supply chains.
Patent CN114667346B reveals a novel EanB mutant for efficient ergothioneine production. Discover cost-effective, scalable enzymatic synthesis solutions for global supply chains.
Novel enzymatic route reduces cost and environmental impact for high-purity pharmaceutical intermediate manufacturing supply chains ensuring reliable global sourcing and scalable production capabilities for advanced antifungal drug development projects.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN120624386B reveals a high-pH stable alcohol dehydrogenase mutant for natural raspberry ketone. Enables cost reduction and scalable supply for flavor industries.
Patent CN113234696B details a novel in vitro enzymatic route for crocetin from zeaxanthin, offering superior purity and scalable production for fine chemical manufacturing.
Patent CN105002234B reveals enzymatic cAMP synthesis. Offers high purity, cost reduction, and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN106978368B details a novel nitrilase biocatalysis route for L-glufosinate precursors, offering high optical purity and reduced environmental impact for agrochemical manufacturing.
Patent CN114277073A reveals gene-knockout method for high-purity SAM. Reduces purification costs and ensures supply chain stability for pharmaceutical intermediates.
Patent CN107922952B enables cost-effective NMN synthesis without PRPP. Discover scalable biocatalytic routes for high-purity pharmaceutical intermediates.
Patent CN110218758A reveals enzymatic lutein ester synthesis offering high purity and mild conditions for reliable pharmaceutical intermediate supply chain optimization.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN113151375B reveals enzymatic synthesis improving yield and safety. Reliable supplier for cost reduction in sweetener manufacturing and supply chain stability.
Patent CN102978267B reveals advanced enzymatic glutathione production with ATP regeneration. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110540975B reveals high-efficiency biocatalytic route for sitagliptin precursors, offering superior stereoselectivity and reduced environmental impact for pharma supply chains.
Patent CN108026130B reveals enzyme mutant method for NMN. Low cost, high purity, scalable supply chain solution for global buyers.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN109943582A reveals high-efficiency DDC catalysis for dopamine. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel one-step enzymatic route for L-carnosine reduces cost and complexity. Reliable supply chain partner for high-purity pharmaceutical intermediates and scalable production.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.